Pulmonary Infographic: Real-time Patient Insights from Medisafe

5 Sep 2019

Highlights from the Pulmonary Infographic

  • The U.S. trails other nations in pulmonary medication adherence on Medisafe
  • Like many therapeutic areas, Saturday and Sunday prove
    the most challenging for pulmonary medication adherence
  • Pulmonary medication adherence peaks in the
    morning hours
  • Worldwide medication adherence rates for most pulmonary conditions average 76% on Medisafe
  • Of the top pulmonary drugs with the highest reported
    adherence on Medisafe, GlaxoSmithKline holds 6 spots


What insights can we discover about your brand? Contact us to find out!


Full Pulmonary Adherence Insights

Most Adherent Countries For Pulmonary Meds

  • Germany: 84%
  • Italy: 82%
  • Argentina: 80%
  • France: 80%
  • Brazil: 79%
  • Mexico: 79%
  • Netherlands: 79%
  • Spain: 79%
  • Canada: 78%
  • UK: 76%
  • Australia: 75%
  • Puerto Rico: 75%
  • Saudi Arabia: 75%
  • Turkey: 75%
  • USA: 75%

How Day Of Week Affect Pulmonary Med Adherence

  • Sunday: 72%
  • Monday: 83%
  • Tuesday: 78%
  • Wednesday: 76%
  • Thursday: 75%
  • Friday: 74%
  • Saturday: 74%

Adherence Rates By Type Of Pulmonary Treatment

  • Bronchitis: 84%
  • Pneumonia / COPD: 80%
  • Asthma: 79%
  • Bronchospasm Diagnosis: 76%
  • Aspiration Prophylaxis: 75%
  • Acute Bronchospasm: 73%
  • Atelectasis: 71%

Why Pulmonary Patients Say They Miss Doses

  • Didn’t need dose: 36%
  • Other: 23%
  • Forgot/ Busy: 19%
  • Med wasn’t nearby: 13%
  • Ran out of meds: 5%
  • Worried about side effects: 3%
  • Worried about cost: 1%

Top Pulmonary Meds With Highest Adherence

Brand Company Adherence
Xolair Genentech (US), Novartis 84%
Entocort EC Perrigo (US), AstraZeneca 84%
DALIRESP AstraZeneca 82%
Spiriva Boehringer Ingleheim 82%
Symbicort AstraZeneca 82%
Ofev Boehringer Ingleheim 81%
Xopenex HFA Sunovion 78%
Breo Ellipta GSK 77%
Singulair Merck 77%
Serevent GSK 77%
Anoro Ellipta GSK 77%
Ventolin HFA GSK 77%
Pulmicort AstraZeneca 75%
Esbriet Genentech 74%
ProAir HFA Teva 74%
Proventil HFA Merck 74%
Asmanex Merck 74%
Advair GSK 72%
Ventolin Nubeles NuCare 71%
Dulera Merck 71%
QVAR Teva 71%
Flovent GSK 71%
Xopenex HFA Inhaler Sunovion 69%
Xopenex Sunovion 69%
Orkambi Vertex 69%

What insights can we discover about your brand? Contact us to find out!

You may also like

Infographics

Medisafe’s Digital Companion Launch Toolkit

This free launch toolkit has the must-have answers and best practices for all eight stages of a successful digital  launch. 

..Read More
Infographics

Digital health increases pharma’s engagement with patients

Discover how new technologies are driving the growth of digital health companions, and how these tools are advancing pharma.

..Read More
Infographics

Mental Health Infographic: Real-time Patient Insights from Medisafe

Highlights from the Mental Health Infographic In general, mental illness med adherence is higher in Europe than the United States 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.